268 related articles for article (PubMed ID: 16291487)
1. Availability of medical abortion pills and the role of chemists: a study from Bihar and Jharkhand, India.
Ganatra B; Manning V; Pallipamulla SP
Reprod Health Matters; 2005 Nov; 13(26):65-74. PubMed ID: 16291487
[TBL] [Abstract][Full Text] [Related]
2. Availability and acceptability of medical abortion in Nepal: health care providers' perspectives.
Tamang A; Tamang J
Reprod Health Matters; 2005 Nov; 13(26):110-9. PubMed ID: 16291492
[TBL] [Abstract][Full Text] [Related]
3. [The efficacy and acceptability of mifepristone medical abortion with home administration misoprostol provided by private providers linked with the hospital: a prospective study of 433 patients].
Faucher P; Baunot N; Madelenat P
Gynecol Obstet Fertil; 2005 Apr; 33(4):220-7. PubMed ID: 15894206
[TBL] [Abstract][Full Text] [Related]
4. The true cost differential between mifepristone and misoprostol and misoprostol-alone regimens for medical abortion.
Creinin MD; Shore E; Balasubramanian S; Harwood B
Contraception; 2005 Jan; 71(1):26-30. PubMed ID: 15639068
[TBL] [Abstract][Full Text] [Related]
5. Using telemedicine for termination of pregnancy with mifepristone and misoprostol in settings where there is no access to safe services.
Gomperts RJ; Jelinska K; Davies S; Gemzell-Danielsson K; Kleiverda G
BJOG; 2008 Aug; 115(9):1171-5; discussion 1175-8. PubMed ID: 18637010
[TBL] [Abstract][Full Text] [Related]
6. Mifepristone plus vaginal misoprostol vs vaginal misoprostol alone for medical abortion in gestation 63 days or less in Nepalese women: a quasi-randomized controlled trial.
Chawdhary R; Rana A; Pradhan N
J Obstet Gynaecol Res; 2009 Feb; 35(1):78-85. PubMed ID: 19215552
[TBL] [Abstract][Full Text] [Related]
7. Study supports the introduction of early medical abortion in Turkey.
Akin A; Kocoglu GO; Akin L
Reprod Health Matters; 2005 Nov; 13(26):101-9. PubMed ID: 16291491
[TBL] [Abstract][Full Text] [Related]
8. Increasing women's choices in medical abortion: a study of misoprostol 400 microg swallowed immediately or held sublingually following 200 mg mifepristone.
Akin A; Dabash R; Dilbaz B; Aktün H; Dursun P; Kiran S; Aksan G; Doğan B; Winikoff B
Eur J Contracept Reprod Health Care; 2009 Jun; 14(3):169-75. PubMed ID: 19565414
[TBL] [Abstract][Full Text] [Related]
9. Are two doses of misoprostol after mifepristone for early abortion better than one?
Coyaji K; Krishna U; Ambardekar S; Bracken H; Raote V; Mandlekar A; Winikoff B
BJOG; 2007 Mar; 114(3):271-8. PubMed ID: 17217359
[TBL] [Abstract][Full Text] [Related]
10. Second trimester medical abortion with mifepristone-misoprostol and misoprostol alone: a review of methods and management.
Gemzell-Danielsson K; Lalitkumar S
Reprod Health Matters; 2008 May; 16(31 Suppl):162-72. PubMed ID: 18772097
[TBL] [Abstract][Full Text] [Related]
11. Increasing access to safe abortion services in rural India: experiences with medical abortion in a primary health center.
Mundle S; Elul B; Anand A; Kalyanwala S; Ughade S
Contraception; 2007 Jul; 76(1):66-70. PubMed ID: 17586140
[TBL] [Abstract][Full Text] [Related]
12. Regimens of misoprostol with mifepristone for early medical abortion: a randomised trial.
Shannon C; Wiebe E; Jacot F; Guilbert E; Dunn S; Sheldon WR; Winikoff B
BJOG; 2006 Jun; 113(6):621-8. PubMed ID: 16709204
[TBL] [Abstract][Full Text] [Related]
13. Mifepristone followed in 24 hours to 48 hours by misoprostol for late first-trimester abortion.
Bracken H; Ngoc NT; Schaff E; Coyaji K; Ambardekar S; Westheimer E; Winikoff B
Obstet Gynecol; 2007 Apr; 109(4):895-901. PubMed ID: 17400851
[TBL] [Abstract][Full Text] [Related]
14. Support for provision of early medical abortion by mid-level providers in Bihar and Jharkhand, India.
Patel L; Bennett TA; Halpern CT; Johnston HB; Suchindran CM
Reprod Health Matters; 2009 May; 17(33):70-9. PubMed ID: 19523584
[TBL] [Abstract][Full Text] [Related]
15. Simultaneous very low dose mifepristone and vaginal misoprostol for medical abortion.
Kapp N; Borgatta L; Ellis SC; Stubblefield P
Contraception; 2006 May; 73(5):525-7. PubMed ID: 16627039
[TBL] [Abstract][Full Text] [Related]
16. Mifepristone- and misoprostol-induced mid-trimester termination of pregnancy: a review of 272 cases.
Rose SB; Shand C; Simmons A
Aust N Z J Obstet Gynaecol; 2006 Dec; 46(6):479-85. PubMed ID: 17116051
[TBL] [Abstract][Full Text] [Related]
17. Mifepristone and misoprostol administered simultaneously versus 24 hours apart for abortion: a randomized controlled trial.
Creinin MD; Schreiber CA; Bednarek P; Lintu H; Wagner MS; Meyn LA;
Obstet Gynecol; 2007 Apr; 109(4):885-94. PubMed ID: 17400850
[TBL] [Abstract][Full Text] [Related]
18. Induction of second trimester abortion (12-20 weeks) with mifepristone and misoprostol: a review of 386 consecutive cases.
Goh SE; Thong KJ
Contraception; 2006 May; 73(5):516-9. PubMed ID: 16627037
[TBL] [Abstract][Full Text] [Related]
19. Two mifepristone doses and two intervals of misoprostol administration for termination of early pregnancy: a randomised factorial controlled equivalence trial.
von Hertzen H; Piaggio G; Wojdyla D; Marions L; My Huong NT; Tang OS; Fang AH; Wu SC; Kalmar L; Mittal S; Erdenetungalag R; Horga M; Pretnar-Darovec A; Kapamadzija A; Dickson K; Anh ND; Tai NV; Tuyet HT; Peregoudov A;
BJOG; 2009 Feb; 116(3):381-9. PubMed ID: 19187370
[TBL] [Abstract][Full Text] [Related]
20. A randomized trial to compare two dosing intervals of misoprostol following mifepristone administration in second trimester medical abortion.
Chai J; Tang OS; Hong QQ; Chen QF; Cheng LN; Ng E; Ho PC
Hum Reprod; 2009 Feb; 24(2):320-4. PubMed ID: 19049993
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]